RedHill Biopharma Ltd - Company Profile
Powered by 
All the data and insights you need on RedHill Biopharma Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date RedHill Biopharma Ltd Strategy Report
- Understand RedHill Biopharma Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
RedHill Biopharma Insights
Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.
A sample of RedHill Biopharma Insights data
| Headline | Published | Journalists |
|---|---|---|
| Deserunt mollit sunt Lorem laborum do id aliqua dolore | 19 Oct 2018 | Lorem |
| RedHill’s Phase III RHB-104 study in Crohn's unlikely to improve on Pfizer's attempt; primary endpoint modifications unlikely to clinch win, experts say | 20 Apr 2018 | Krystnell Storr |
| RedHill’s RHB-104 retains doubts on Phase III Crohn’s despite study updates as caution still surrounds MOA rationale, experts say | 20 Apr 2018 | Krystnell Storr |
| Redhill’s Bekinda’s ischemic colitis potential in its Phase II IBS-D trial divides expert opinion, efficacy primary endpoint attainable | 08 Mar 2017 | Alexandra Thompson |
Feature
Delivers exclusive investigative journalist content including breaking news and analysis ahead of market-moving events.
Benefit
Drug Insights:
- Forward-looking, nuanced, qualitative asset analysis on development, approval & market/reimbursement potential
- Material intelligence on competitors, including breaking news
- Insight on companies’ business development needs and strategies
Outsourcing Insights:
Insight on companies’ CRO and business development needs, strategies and relationships
Value
Remove risk and uncertainty
Gain a competitive edge
Secure actionable leads
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer